EKSO Ekso Bionics Holdings, Inc.
Healthcare$11.80+1.29%ClosedMarket Cap: $28.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
7.32
P/S
2.48
EV/EBITDA
-2.17
DCF Value
$-82.59
FCF Yield
-41.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
52.9%
Operating Margin
-134.1%
Net Margin
-135.7%
ROE
-177.4%
ROA
-79.8%
ROIC
-108.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.1M | 50.2% | $-5.6M | $-6.9M | $— | — |
| Q4 null | $3.1M | 53.2% | $-4.5M | $-4.7M | $— | — |
| FY null | $12.8M | 53.5% | $-13.3M | $-11.7M | $— | — |
| Q3 null | $4.2M | 60.3% | $-1.4M | $-1.4M | $— | — |
| Q2 null | $2.1M | 39.8% | $-4.0M | $-2.7M | $— | — |
| Q1 null | $3.4M | 53.5% | $-3.4M | $-2.9M | $— | — |
| Q4 null | $5.1M | 53.3% | $-2.2M | $-3.4M | $— | — |
| FY null | $17.9M | 53.1% | $-10.5M | $-11.3M | $— | — |
| Q3 null | $4.1M | 53.5% | $-2.6M | $-2.1M | $— | — |
| Q2 null | $5.0M | 53.3% | $-2.3M | $-2.4M | $— | — |
| Q1 null | $3.8M | 51.9% | $-3.3M | $-3.4M | $— | — |
| Q4 2023 | $4.8M | 48.9% | $-3.4M | $-3.2M | $-0.22 | — |